When launched, Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine...
France headquartered genOway, a public company and leader in developing genetically modified research models, has announ...
Colgate has introduced a first-of-its-kind smart toothbrush with new optic sensor technology that detects biofilm buildu...
US based Pulmatrix, Inc., a clinical stage biopharmaceutical company developing innovative inhaled therapies to address ...
GlaxoSmithKline has announced the completion of the divestment of travel vaccines Rabipur (tradename Rabavert in the US)...
US based Purdue University drug discovery researchers have created a new framework for mining data for training mac...
The spinal muscular atrophy (SMA) market across the five growth markets ((5GM) Australia, China, India, Japan and South ...
Asia has driven a boom in recent years in terms of R&D spending, venture capital funding, academic publications, and...
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, today announced ...
The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...
Swedish company BioInvent International AB has announced that Pfizer Inc. has selected the second target under the compa...
The U.S. Food and Drug Administration has announced the approval of Ervebo, the first FDA-approved vaccine for the preve...
Merck, a leading science and technology company has signed a license agreement providing Promega Corp., a glob...
BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 mill...
Romaco Holding GmbH, on 17 Dec 2019, announced the appointment of Markus Kimpel as the new Group CFO as well as Managing...
Roche has announced the CE-IVD launch of the cobas® Zika test for use on the cobas® 6800/8800 Sys...
The U.S. Food and Drug Administration has authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an int...
BioIVT, a leading provider of research models and services for drug and diagnostic development, on 16 Dec 2019, launched...
